Worg Pharmaceuticals Funding: $243M Raised, Series D (2023)
Worg Pharmaceuticals is based in Shanghai, China. It has raised $243M in total funding. Latest round: Series D.
Worg Pharmaceuticals funding overview
Worg Pharmaceuticals is based in Shanghai, China. Worg Pharmaceuticals has raised $243M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in June 2023. The round record for Worg Pharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include DT Capital Partners, Bairun Investment, YSIM Fund, Jiansu Capital, Kequan Fund, Bayland Capital. 6 distinct backers are named across the disclosed rounds.
Worg Pharmaceuticals at a glance
Total raised
$243M
Latest round
Series D
Latest round date
June 2023
Headquarters
Shanghai, China
Notable investors
DT Capital Partners, Bairun Investment, YSIM Fund, Jiansu Capital, Kequan Fund, Bayland Capital
Frequently asked about Worg Pharmaceuticals funding
How much has Worg Pharmaceuticals raised?
Worg Pharmaceuticals has raised $243M in total disclosed funding across the rounds on record.
Who has invested in Worg Pharmaceuticals?
DT Capital Partners, Bairun Investment, YSIM Fund, Jiansu Capital, Kequan Fund, Bayland Capital are named among the investors backing Worg Pharmaceuticals.
What was the latest Worg Pharmaceuticals funding round?
The most recent disclosed round is a Series D, announced in June 2023.
Where is Worg Pharmaceuticals based?
Worg Pharmaceuticals is based in Shanghai, China.
When did Worg Pharmaceuticals last raise?
The last disclosed Worg Pharmaceuticals round closed in June 2023 at Series D.
Round data for Worg Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.
